J&J to ship children’s medicine amid House committee hearing
WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children’s medicines following a nationwide recall.
J&J CEO William Weldon said nearly 1 million bottles of the medicine — which he did not disclose — will be available for release next week. The drug maker met with the House Committee on Oversight and Government Reform on Thursday to examine the circumstances surrounding J&J’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.
On Sept. 16, J&J’s consumer group chair Colleen Goggins said she would retire from her post on March 1, 2011.
HerbaSway introduces Last Round to cap off night
WALLINGFORD, Conn. HerbaSway has introduced a hangover support in a ready-to-drink single “shot.”
Last Round is a 2.5-oz. bottle that contains such ingredients as kudzu root, stevia and green tea extracts. Last Round works by removing the effects of alcohol, “relaxing” the flow of blood and oxygen to the brain, and detoxifying the body so users avoid headaches, dry mouth and other ailments associated with hangovers, the company said. HerbaSway also recommended drinking one 2.5-oz. bottle of Last Round just before bedtime.
“Our whole philosophy at HerbaSway revolves around living a natural lifestyle, and as a natural hangover support, Last Round fits perfectly alongside our other product lines,” said Robert Wolfson, president of HerbaSway. “Drinking moderately and responsibly also fits into our philosophy, but we recognize that there are times when people go a little overboard. On these occasions, a final shot of Last Round provides protection against hangovers the next day. As we say on the bottle, it’s the best way to end a night of drinking.”
Last Round is available online and at retail shops nationwide, including Whole Foods. It is sold in two-packs, six-packs, 12-packs and party packs of 50 bottles.
Abbott’s multipurpose disinfecting solution for contacts gets FDA OK
ABBOTT PARK, Ill. Abbott has received market clearance from the Food and Drug Administration for RevitaLens Ocutec, a multipurpose disinfecting solution for silicone hydrogel and conventional soft contact lenses.
"This advanced, next-generation solution establishes a new standard of disinfecting technology for contact lens wearers," stated Jim Mazzo, SVP Abbott Medical Optics. "Proper contact lens care, including a rub and rinse regimen using RevitaLens Ocutec, will help patients achieve clean and comfortable lenses while enhancing overall lens-wearing satisfaction."
RevitaLens Ocutec multipurpose disinfecting solution was developed in cooperation with silicone hydrogel, microbiology and chemistry experts and with input from more than 600 eye care professionals.
It is estimated that there are 125 million contact lens wearers worldwide. Multipurpose solutions represent the majority of systems used for the care of soft contact lenses. These are comprised of a single solution for the rinsing, cleaning, disinfection and storage of lenses, and typically are composed of a preservative, buffer system and other agents to aid in lens cleaning and comfort.
Key characteristics of RevitaLens Ocutec multipurpose disinfecting solution include:
- High micro-organism kill rates;
- Removes proteins from the lens surface;
- Effectively kills acanthamoeba and fusarium;
- Reduces corneal staining; and
- Minimizes the risk of eye complications.
Abbott plans to begin retail shipment of RevitaLens Ocutec multipurpose disinfecting solution in the United States in October. The product also has CE Mark approval in Europe.